CRP/DHEA-S Ratio: What Inflammation Versus Recovery Reserve Reveals

What the CRP/DHEA-S ratio actually captures

The CRP/DHEA-S ratio divides hs-CRP by DHEA-S to compare inflammation load against anabolic-recovery capacity in a single number. CRP is made by the liver in response to immune signaling and reflects active inflammatory activity; DHEA-S is a stable, sulfated adrenal hormone that serves as a long-lived reservoir for DHEA and carries immunomodulatory effects. Together they frame the balance between wear-and-tear and the body's capacity to repair it. Morgan and colleagues identified this pairing in research linking higher ratios with all-cause mortality risk in older adults, situating it within the broader "inflammaging" literature. Because CRP and DHEA-S are measured in different unit systems and vary by sex and age, no single universal cutoff exists; the ratio is most meaningful as a personal trend tracked at the same lab over time.

Why inflammation versus repair capacity is the real question

Neither marker tells the full story alone. CRP reflects the active inflammatory load at the moment of the draw — interleukin-6 and other cytokines instruct the liver to produce it, and it decays with a half-life of roughly 19 hours once the triggering signal subsides. DHEA-S represents something structurally different: the adrenal anabolic reserve. It is produced in the zona reticularis and acts as a long-lived pool that converts to active androgens in peripheral tissues, dampening excessive inflammatory signaling in some models while supporting muscle and connective tissue repair.

What makes the ratio more informative than either marker in isolation is the interplay between these two axes. DHEA-S declines approximately 10% per decade from the mid-20s onward — a structural, age-driven trajectory. But it is also acutely suppressed when cortisol is chronically elevated: cortisol and DHEA synthesis compete for precursor in the zona reticularis, so sustained stress tilts adrenal output away from DHEA-S independent of age. The result is that a person under chronic psychosocial or physiological stress can carry a lower DHEA-S than their age alone would predict, while simultaneously running higher CRP from the same stress-driven cytokine tone. Neither marker alone captures this convergence of inflammaging and anabolic depletion; the ratio does.

Computing the CRP/DHEA-S ratio from serum

Formula:

CRP/DHEA-S Ratio = hs-CRP (mg/L) ÷ DHEA-S (µg/dL)

Unit caveat: hs-CRP is reported in mg/L and DHEA-S in µg/dL — two different unit systems. The ratio's numeric value is therefore not directly comparable across labs unless units are confirmed. Some laboratories and research papers report CRP in mg/dL rather than mg/L; a ratio calculated from mg/dL values will be 10× smaller than one calculated from mg/L values. Always confirm units before calculating or comparing results across draws or providers.

Collection notes: Neither hs-CRP nor DHEA-S requires fasting. DHEA-S has minimal diurnal variation, making timing of the draw flexible. hs-CRP should ideally not be drawn during acute illness or within two weeks of a vaccine, as the acute-phase response will transiently elevate it and distort the inflammatory baseline.

Worked example: A 45-year-old with hs-CRP of 1.5 mg/L and DHEA-S of 150 µg/dL has a CRP/DHEA-S ratio of 1.5 ÷ 150 = 0.010. A 65-year-old with a similar lifestyle but hs-CRP of 2.5 mg/L and age-reduced DHEA-S of 80 µg/dL has a ratio of 2.5 ÷ 80 = 0.031 — a higher ratio reflecting both modest CRP elevation and substantial DHEA-S age decline, a pattern consistent with the inflammaging trajectory observed in cohort research.

Reading your CRP/DHEA-S number against your trend

Because the CRP/DHEA-S ratio is not a standardized clinical tool, there is no universally accepted numeric cutoff for the ratio itself. Units differ across labs and reference intervals differ by sex and age. The most credible use is to trend your own data — same lab, same assay type, similar timing, consistent health baseline — and interpret with a clinician who knows your history. A single number is a starting point; a direction over multiple draws is the signal.

In the absence of ratio-specific cutoffs, the component markers provide contextual framing:

• hs-CRP below 1 mg/L: Associated with lower cardiovascular risk in large population studies. When the numerator sits here and DHEA-S is age-appropriate, the ratio is likely in a reassuring range.
• hs-CRP 1–3 mg/L: Associated with average cardiovascular risk. A ratio driven by a numerator in this band warrants attention to trend direction, particularly if DHEA-S is also declining.
• hs-CRP above 3 mg/L: Associated with higher cardiovascular risk when persistent and not explained by acute illness, recent vaccine, or injury. A ratio with a numerator here — especially paired with low or falling DHEA-S — reflects the combined inflammatory-anabolic imbalance the ratio is designed to surface.
• DHEA-S in the lower portion of the age- and sex-expected range: Even with a modest hs-CRP, a denominator that is low for age amplifies the ratio and may reflect accelerated adrenal decline, chronic stress axis suppression, or medication effects.
• DHEA-S unusually elevated (e.g., in some presentations of polycystic ovary syndrome or rare adrenal causes): The ratio may appear reassuringly low, but a very high DHEA-S is not automatically favorable and points back to clinical context.

Context is everything. A transient CRP bump after a half marathon, a vaccine, or a brief illness is expected and does not redefine your baseline. Correlating the ratio with other markers — such as ApoB for lipid-related risk or HbA1c for glycemic load — sharpens the picture. This ratio is not a diagnosis.

What pushes the CRP/DHEA-S ratio higher

The IL-6/cytokine axis and CRP

Interleukin-6 and related cytokines are the primary upstream drivers of hepatic CRP production. Visceral adipose tissue is a chronic, low-grade source of IL-6, meaning excess central adiposity sustains a background inflammatory signal independent of acute events. Dietary patterns that reduce glycemic load and increase omega-3 intake are associated with lower baseline CRP in observational and interventional research, likely through reduced glycation stress and a shift in eicosanoid balance toward fewer pro-inflammatory mediators. Smoking, certain environmental exposures, active autoimmune disease, and unresolved dental or tissue infections can also sustain CRP elevation.

The DHEA-S age trajectory

DHEA-S declines approximately 10% per decade from the mid-20s onward. This age-driven fall is the structural backdrop behind the ratio's natural tendency to rise over a lifetime — even in the absence of any change in inflammatory load, a shrinking denominator pushes the ratio higher. This trajectory is not modifiable in the way CRP is, but it is important context for interpreting any given ratio value: a ratio that looks elevated in a 65-year-old may partly reflect normal adrenal aging rather than pathological inflammation.

Chronic stress and the cortisol-DHEA-S axis

Cortisol and DHEA synthesis share precursor pathways in the adrenal zona reticularis. When cortisol output is chronically elevated — whether from psychosocial stress, sleep disruption, or physiological stressors — DHEA synthesis is competitively suppressed. This means high cortisol tone is associated with lower DHEA-S independent of age, worsening the denominator of the ratio at the same time that stress-driven cytokine signaling may be elevating the numerator.

Sleep

Sleep debt sustains sympathetic nervous system tone and cytokine signaling simultaneously. Even a few nights of insufficient sleep can nudge CRP higher; persistent sleep disruption is linked with altered adrenal output patterns that can reduce DHEA-S relative to stress demand. Sleep therefore affects both components of the ratio in the same unfavorable direction.

Medications and other clinical factors

Glucocorticoids suppress ACTH, which reduces adrenal DHEA-S output, worsening the denominator. They may also suppress CRP acutely, creating a misleadingly low numerator. Statins lower hs-CRP independent of their cholesterol-lowering effects, which can reduce the numerator without any change in underlying inflammatory biology. Hormonal contraceptives may reduce DHEA-S; androgenic medications can raise it. Pregnancy, PCOS, and rare adrenal disorders shift both markers in ways that require clinical interpretation before the ratio is meaningful.

Markers that contextualize the CRP/DHEA-S ratio

• hs-CRP — the numerator; standalone hs-CRP provides the cardiovascular risk benchmarks (<1, 1–3, >3 mg/L) that give clinical framing to the ratio's inflammatory component.
• DHEA-S — the denominator; a standalone DHEA-S result establishes where in the age- and sex-expected decline trajectory the value sits, separating normal aging from stress-driven or medication-driven suppression.
• Cortisol — DHEA-S and cortisol are both ACTH-linked adrenal outputs; a high cortisol paired with low DHEA-S adds the stress-axis dimension that the CRP/DHEA-S ratio cannot distinguish on its own.
• ApoB — when CRP is elevated, cardiovascular risk compounds with ApoB burden; a high CRP/DHEA-S ratio alongside high ApoB identifies a combined inflammatory-atherogenic risk cluster that warrants closer clinical attention.
• HbA1c — elevated HbA1c often tracks with higher CRP via glycation stress and visceral fat accumulation; pairing glycemic with inflammatory data situates the ratio in its metabolic context.

Why CRP/DHEA-S needs a months-long retest window

The two components of this ratio move on very different timescales. hs-CRP is fast — it rises within hours of an inflammatory trigger and decays with a half-life of roughly 19 hours. DHEA-S is slow — it reflects adrenal output accumulated over weeks to months and responds to interventions, aging, and stress-axis changes over that same longer horizon. Because the ratio's meaningful trend is set by the DHEA-S trajectory, pacing retests to the slower component is essential.

A 3-month retest can confirm the direction of CRP after a lifestyle change — for example, after improving sleep consistency or shifting dietary pattern. The 6–12 month window is needed to detect a meaningful shift in DHEA-S and therefore in the ratio itself. Retesting sooner than 6 months is unlikely to capture a true DHEA-S change and may produce a misleading comparison.

Timing and consistency matter for valid trend comparison:

• Do not draw hs-CRP within two weeks of an acute illness, vaccine, or major physical stressor — the acute-phase spike will distort the inflammatory baseline and make the ratio uninterpretable as a trend point.
• Use the same laboratory and the same assay type (hs-CRP, not standard CRP) for every draw. Switching assay type or lab between draws invalidates the trend because reference ranges, sensitivity thresholds, and unit conventions may differ.
• Draw at a stable health baseline — not during a heavy training block, active infection, or period of acute high stress — to ensure the result reflects your underlying physiology rather than a transient perturbation.

When CRP/DHEA-S warrants a clinician's read

A single elevated ratio is rarely an emergency, but certain patterns deserve a clinician's attention rather than self-interpretation. Bring the ratio to a clinician if:

• The ratio is persistently elevated across two or more draws taken at a stable health baseline, separated by at least three months.
• hs-CRP is consistently above 3 mg/L without a clear acute explanation such as recent illness, injury, or vaccine.
• DHEA-S is low for age and sex, particularly when paired with elevated cortisol, fatigue, or reduced recovery capacity — a pattern that may reflect stress-axis dysregulation rather than normal aging alone.
• The ratio is rising over serial draws even as lifestyle factors appear stable, suggesting a driver that warrants investigation.
• You are considering or currently taking medications — glucocorticoids, statins, hormonal contraceptives, or androgenic compounds — that directly affect one or both components.
• Companion markers such as ApoB or HbA1c are also out of range, pointing to a combined inflammatory-metabolic risk cluster.

Tracking hs-CRP, DHEA-S, and their ratio over time helps distinguish a one-off blip from a trend tied to training load, nutrition shifts, weight change, new medications, or a stressful season. Numbers are more actionable when paired with how you feel and perform — sleep quality, recovery between sessions, resting heart rate trends. When subjective and objective data move together, the picture sharpens.

Superpower's approach to biomarker testing is built on exactly this kind of longitudinal, whole-system view — watching inflammation, metabolism, hormones, and recovery signals together, in your body, at your pace. The CRP/DHEA-S ratio is one window into that system. Learn more about the Superpower approach or visit superpower.com to access a comprehensive panel that puts this ratio in context alongside the markers that give it meaning.